ZTS

$169.21

▲+0.42%

wb_incandescent Backtest

Stock

Zoetis Inc. Class A Common Stock

Official Company Name: Zoetis Inc.

Stock Symbol: ZTS

Stock Market: New York Stock Exchange - NYSE

Currency: United States dollar - USD

business Zoetis Inc. Company Profile

ZTS Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+4.03%

file_download

Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Zoetis Inc. is a pharmaceutical company particularly engaged in treatments for pets and livestock. It researches, develops, manufactures, and markets medicine, vaccines, and diagnostic products, as well as biodevices, genetic tests, services, and animal health solutions for pets and companion animals, farm animals, and precision livestock farming.

business Zoetis Inc. Company Profile

ZTS Stock Data

Open $168.73
High $171.14
Low $167.41
Close $169.21
Volume 3,395,600
Previous Close $168.51
1-Day Change 0.70
1-Year Change 6.55
Average Daily Volume 2,073,097
52-Week High $200.09
52-Week Low $151.44

ZTS Stock References

warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.